Dan Ferry | LifeSci Advisors, IR |
Dror Harats | CEO |
Sam Backenroth | CFO |
Jonathan Aschoff | ROTH Capital Partners |
Kevin DeGeeter | Oppenheimer |
RK Ramakanth | H.C. Wainwright |
Greetings, and welcome to the VBL Therapeutics First Quarter 2022 Earnings Confernce Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].
As a reminder, this conference is being recorded.